Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
09. May 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16419
Articles 1 - 20 / 328375
Omission of completion axillary dissection in clinically node-negative breast cancer with 1-2 metastatic sentinel lymph nodes.
World J Surg Oncol
Qiao W, Guo X, Li P, Liu Q, Deng M.
PMID: 42104353 [PubMed - as supplied by publisher]
Likelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study.
BMC Prim Care
van Ieperen SKL, van de Laar FA, Akkermans RP, A Uijen A.
PMID: 42104316 [PubMed - as supplied by publisher]
Severe anemia as a risk factor in Japanese patients with ovarian cancer receiving olaparib: a retrospective study.
BMC Cancer
Yamaoka K, Kume M, Matsumoto A, Hirabatake M, Hayashi N, Shimizu T, Aoki T, Muroi N.
PMID: 42104280 [PubMed - as supplied by publisher]
Ensemble machine learning algorithms leveraged on serum proteomics for enhanced early detection of ovarian cancer.
Sci Rep
Ding J, Dong X, Cao L, Zhao L, Ding J, Wang B, Li Y, Liu Z, Han L, Li W, Zhang W, Wang X, Guo B, Huang C, Li X, Guo A, Song L.
PMID: 42103875 [PubMed - as supplied by publisher]
Commentary on Editorial: Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy.
Pract Radiat Oncol
Haffty BG.
PMID: 42103409 [PubMed - in process]
Omitting Radiation for Breast Cancer Patients Eligible for the NSABP B-51 Trial Who Achieve ypN0 After Neoadjuvant Chemotherapy.
Pract Radiat Oncol
Li PC, Recht A.
PMID: 42103408 [PubMed - in process]
Methylation Marks Breast Cancer Metastasis: The Roles of m(6)A-Modified miRNAs and lncRNAs.
J Biol Chem
Humphries BA, Wang Z, Yang C.
PMID: 42103211 [PubMed - as supplied by publisher]
The VEGF/VEGFR axis in triple-negative breast cancer: a comprehensive review of therapeutic strategies.
Gene
Han MI, Atalay P, Satir-Basaran G.
PMID: 42103175 [PubMed - as supplied by publisher]
Is platinum the New gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies.
J Control Release
Roa AP, Muthuramalingam RPK, Lopez-Sanchez A, Deng LW, Gibson D, Bertrand HC, Adriani G, Ang WH, Pastorin G.
PMID: 42103028 [PubMed - as supplied by publisher]
Risk, prevalence and survival outcomes of ovarian cancer in women with endometriosis: the ENDOCANCER systematic review and meta-analysis.
J Minim Invasive Gynecol
Piacenti I, Tius V, Gomba B, Restaino S, Arcieri M, Zermano S, Biasioli A, Perelli F, Raimondo D, Lazzeri L, Mattei A, Zupi E, Seracchioli R, Vizzielli G.
PMID: 42102910 [PubMed - as supplied by publisher]
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis.
Gynecol Oncol
Lukey A, Salmanpour A, Kaur P, Berchuck A, Chase A, Dawson L, Grout B, Deurloo CM, Richardson J, Stuart G, Terry KL, Webb PM, Pike MC, Pearce CL, Hanley GE.
PMID: 42102524 [PubMed - as supplied by publisher]
Unique Considerations in Rare Gynecologic Tumors: Gestational Trophoblastic Neoplasia, Germ Cell Tumors, and Clear Cell Ovarian Cancers.
Am Soc Clin Oncol Educ Book
Farley JH, Fujiwara K, Lee JY, Tan DSP, Horowitz NS.
PMID: 42102342 [PubMed - indexed for MEDLINE]
An exploratory dosimetric and treatment-time analysis of tangent-arc and continuous semi-arc VMAT in deep inspiration breath-hold radiotherapy for stage I left-sided breast cancer.
PLoS One
Li Y, Chen Y, Xu C, Zhan W, Shao K, Jia Y, Zhang H, Qiu L, Ding J, Chen W.
PMID: 42102159 [PubMed - indexed for MEDLINE]
Comparative efficacy of prevention strategies for oral mucositis in breast cancer patients: a network meta-analysis.
Breast Cancer Res Treat
Liu Q, Wang R, Jiang S, Yuan J, He G, Wang Q, Cheng S, Chen L, Zhao L, Liu S.
PMID: 42101732 [PubMed - indexed for MEDLINE]
Integrative analysis of tumor-educated platelets for stage-specific diagnosis, prognosis, and therapy in ovarian cancer.
Discov Oncol
Gahin SG, Ibrahim MS, Badr E.
PMID: 42101729 [PubMed]
Circadian clock control of breast cancer hallmarks: molecular mechanisms and therapeutic implications.
Cancer Metastasis Rev
Hernández-Barrientos LR, Aguilar-Arnal L.
PMID: 42101677 [PubMed - indexed for MEDLINE]
Flavonol-mediated modulation of angiogenesis-related microRNAs in breast cancer: a narrative synthesis of current evidence and knowledge gaps.
Future Oncol
Ramali DP, Maphoso TM, Mulaudzi TV, Ambele M, Maharaj V, Mabeta P, Damane BP.
PMID: 42100959 [PubMed - as supplied by publisher]
Integrated study reveals molecular mechanisms by which bisphenol A promotes ovarian cancer.
iScience
Geng H, Zhu J, Zhang W, Liu M.
PMID: 42100745 [PubMed]
Mortality prediction with adjuvant tamoxifen in breast cancer: Machine learning-integrated explainable artificial intelligence and Bayesian model results.
ADMET DMPK
Sridharan K, Sivaramakrishnan G.
PMID: 42100630 [PubMed]
The role of pluripotency regulators in triple-negative breast cancer immune response.
Front Genet
López-Santana C, Mendez-Rivera F, Bernal-Estévez DA.
PMID: 42100345 [PubMed]
Articles 1 - 20 / 328375
Page 1 of 16419
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy